The reply
Am J Med
.
2014 Feb;127(2):e11-2.
doi: 10.1016/j.amjmed.2013.09.029.
Epub 2013 Oct 15.
Authors
Mark S Klempner
1
,
Phillip J Baker
2
,
Eugene D Shapiro
3
,
Adriana Marques
4
,
Raymond J Dattwyler
5
,
John J Halperin
6
,
Gary P Wormser
7
Affiliations
1
University of Massachusetts Medical School, Boston, Mass.
2
American Lyme Disease Foundation, Lyme, Conn.
3
Departments of Pediatrics, Epidemiology, and Public Health, and Investigative Medicine, Yale University, New Haven, Conn.
4
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
5
Division of Allergy, Immunology and Rheumatology, Department of Medicine, New York Medical College, Valhalla, NY.
6
Department of Neurosciences, Overlook Medical Center and Atlantic Neuroscience Institute, Summit, NJ.
7
Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY.
PMID:
24462014
DOI:
10.1016/j.amjmed.2013.09.029
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use*
Borrelia burgdorferi*
Humans
Lyme Disease / drug therapy*
Substances
Anti-Bacterial Agents
Grants and funding
KL2 TR001862/TR/NCATS NIH HHS/United States